Thu, Apr 17, 2014, 9:32 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • slumdawg2011 slumdawg2011 Sep 26, 2013 10:03 PM Flag

    If SGEN gets bought out...

    I won't be surprised if IMGN rises slowly towards $25 within a month of SGEN's buyout and by end of 2014. Let's wish SGEN well. I have more in IMGN now than with SGEN with the constant dip buying.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • why all the talk about SGEN being acquired? CLDX is trading more like a stock that's about to be acquired. Both are very expensive compared to IMGN, assuming IMGN gets new management. If you look at all of the clinical trials underway, most of the 10 compounds should report news next year. Roche is investing a boat load in Kadcyla trials. The technology works, in the right hands. Not betting on 901, but something in their pipeline will eventually cause IMGN to be like PCYC, SGEN...I hope it happens soon, but I think 289 is their best molecule/compound to date and it's a long way from market even if it gets on the fast track.

    • I was strongly of this opinion a year ago, but am somewhat backing off it now.

      I suspect that an SGEN buyout would cause a quick pop for IMGN well over $20, but might not last.

      The players seam to have given up on IMGN's pipeline. And I am not certain I can blame them.

 
IMGN
13.99-0.22(-1.55%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.